SLC5A2 and type 2 diabetes mellitus: (Kashiwagi et al., 2015).Dapagliflozin is highly potent, reversible, and selectively inhibits sodium-glucose cotransporter-2, making it a widely used medication for treating type 2 diabetes mellitus.